Similar associations were found in the fifth quintile of PUFA intake compared to the first quintile for risk after age 50 years (HR: 0.55, 95% CI: 0.32–0.95) for ER+ tumours and: 0.52, 95% CI: 0.28–0.98) for PR+ tumours. Here, PGR is linked to neoplasm.